Envestnet Asset Management Inc. Purchases 10,876 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Envestnet Asset Management Inc. grew its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 180,802 shares of the company’s stock after acquiring an additional 10,876 shares during the quarter. Envestnet Asset Management Inc. owned about 0.36% of Prestige Consumer Healthcare worth $15,544,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of PBH. Opal Wealth Advisors LLC bought a new position in Prestige Consumer Healthcare in the 1st quarter valued at $38,000. CIBC Private Wealth Group LLC lifted its position in shares of Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after buying an additional 152 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at $40,000. McIlrath & Eck LLC lifted its position in shares of Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock valued at $75,000 after buying an additional 154 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at $93,000. Institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on PBH shares. Royal Bank Of Canada raised Prestige Consumer Healthcare to a “hold” rating in a report on Thursday, May 8th. Wall Street Zen raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $93.33.

Prestige Consumer Healthcare Trading Up 0.0%

PBH opened at $75.20 on Friday. The stock has a market cap of $3.72 billion, a price-to-earnings ratio of 17.53, a P/E/G ratio of 2.25 and a beta of 0.43. The stock’s 50 day moving average price is $83.16 and its 200-day moving average price is $82.28. Prestige Consumer Healthcare Inc. has a one year low of $64.94 and a one year high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The company had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. During the same quarter in the prior year, the business earned $1.02 earnings per share. Prestige Consumer Healthcare’s revenue was up 7.0% on a year-over-year basis. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.